Lea Monday is an Infectious Disease physician affiliated with Oakland University. OpenAlex indexes 60 publications with 310 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
1 company with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
60.9%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor21.9%Juluca100%Part D<11 patientsProtease Inhibitor17.2%Prezcobix58%Symtuza42%Part D<11 patients+ 2 more classes in this area
Cardiovascular
24.5%Calcium channel blocker14.6%Amlodipine Besylate100%Part D<11 patientsStatin9.9%Atorvastatin Calcium100%Part D<11 patientsRespiratory
14.6%Opioid Agonist14.6%Hydrocodone-Acetaminophen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- P-2027. Advancing Outpatient Infectious Disease Care for Oncology Patients; A Study on Continuity of Care and Clinic Expansion
Open Forum Infectious Diseases
2026 - P-18. Feasibility of PO Step-Down Therapy in Streptococcal Bloodstream Infections: Insights from a Cancer Institute
Open Forum Infectious Diseases
2026 - Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician
Infectious Disease Clinics of North America
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Antonio Capone, MD
Oakland University
Alon Kahana, MD
Oakland University
Ray Bahado-Singh, MD
Oakland University
Jesse Selber, MD
Oakland University
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Myron Cohen, MD
University of North Carolina at Chapel Hill School of Medicine
Derrick W. Crook
John Radcliffe Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”